Current or anticipated use of other investigational agents during the study
Current or anticipated use of other investigational agents or marketed anticancer agent while on study
Current or anticipated use of other investigational agents
Current therapy with any other investigational agents.
Current or anticipated use of other investigational agents
Current receipt of any other investigational agents
no current or prior use of investigational agents within  weeks of study entry.
Current or anticipated use of other investigational agents
DOSE ESCALATION COHORT: Current or anticipated use of other investigational agents while participating in this study
DOSE EXPANSION COHORT: Current or anticipated use of other investigational agents while participating in this study
Current or anticipated use of other investigational agents
Current use of any investigational agents
Current or anticipated use of other investigational agents
Current or past use of investigational agents within  weeks of study enrollment
Current use of other investigational agents
Current or prior treatment for this cancer with immunotherapy and/or any other investigational agents
Current or anticipated use of other investigational agents while participating in this study
Current or anticipated use of other investigational agents
Current therapy with other investigational agents.
Current or anticipated use of other investigational agents
Current use of any other investigational agents
Current use of any other investigational agents
Current use of any other investigational agents
Current use of any other investigational agents
Current use of any investigational agents
